Tags

Tag bidil [5 articles]

Recent papers classified by the tag bidil.

Search Sort Hide Details

	Pharmaceutical Meaning-Making Beyond Marketing: Racialized Subjects of Generic Thiazide The Journal of Law, Medicine & Ethics, Vol. 36, No. 3. (September 2008), pp. 530-536. by Anne Pollock posted to racism race medicine bidil by cgravlee to the group Med Anthro @ UF on 2010-01-21 15:30:46 Abstract Copy My Attachments My Copy Abstract In contrast to discussions of BiDil, this paper explores racial meaning-making processes around an old generic hypertension drug. By unpacking a vignette about race and thiazide outside marketing or medicine, it shows that racialization of drugs exceeds those spheres and moves in unpredictable ways. ...
	Genotyping the Future: Scientists Expectations about Race Ethnicity after BiDil The Journal of Law, Medicine & Ethics, Vol. 36, No. 3. (September 2008), pp. 464-470. by Tutton, Richard, Smart, et al. Andrew, Martin, A. Paul, Ashcroft, Richard, Ellison, T. H. George posted to bidil genetics medicine race by cgravlee to the group Med Anthro @ UF on 2008-09-04 15:08:02 Copy My Attachments My Copy
	Special Treatment: BiDil, Tuskegee, and the Logic of Race The Journal of Law, Medicine & Ethics, Vol. 36, No. 3. (September 2008), pp. 478-484. by Reverby, M. Susan posted to bidil health inequalities medicine race racism by cgravlee to the group Med Anthro @ UF on 2008-09-04 15:05:33 Copy My Attachments My Copy
	Is race-based medicine good for us: African American approaches to race, biomedicine, and equality The Journal of Law, Medicine & Ethics, Vol. 36, No. 3. (September 2008), pp. 537-545. by Dorothy E. Roberts posted to bidil health inequalities medicine race social-justice by cgravlee on 2008-09-04 14:56:25 Copy My Attachments My Copy
	BiDil: Race Medicine Or Race Marketing? Health Aff (Millwood) (11 October 2005) by Pamela Sankar, Jonathan Kahn posted to bidil marketing pharmacogenomics race race-medicine by elsiatcase on 2006-09-29 15:16:40 Abstract Copy My Attachments My Copy Abstract Recent Food and Drug Administration (FDA) approval of the first drug with a race-specific indication has fueled the controversy over the meaning of race and ethnicity and raised questions over whether this move should be seen as an advance or a setback in the struggle to address disparities in health status associated with race. The drug, BiDil, combines two generics long recognized as benefiting patients with heart failure, irrespective of race or ethnicity. The push to bring these drugs to market ...

Note: You may cite this page as: http://www.citeulike.org/tag/bidil

Privacy Statement | Terms & Conditions